A 0 1 0 1 O
biopsy 2 8 2 8 B-treatment
of 9 11 9 11 O
the 12 15 12 15 O
cirrhotic 16 25 16 25 B-chronic_disease
liver 26 31 26 31 I-chronic_disease
( 32 33 32 33 O
non 33 36 33 36 O
- 36 37 36 37 O
surgical 37 45 37 45 O
cohort 46 52 46 52 O
) 52 53 52 53 O

A 0 1 54 55 O
clinical 2 10 56 64 B-treatment
liver 11 16 65 70 I-treatment
biopsy 17 23 71 77 I-treatment
( 24 25 78 79 O
with 25 29 79 83 O
research 30 38 84 92 O
tissue 39 45 93 99 O
specimens 46 55 100 109 O
available 56 65 110 119 O
for 66 69 120 123 O
analysis 70 78 124 132 O
) 78 79 132 133 O
= 80 81 134 135 O
< 81 82 135 136 O
3 83 84 137 138 B-upper_bound
months 85 91 139 145 I-upper_bound
prior 92 97 146 151 I-upper_bound
to 98 100 152 154 O
pre 101 104 155 158 O
- 104 105 158 159 O
registration 105 117 159 171 O

An 0 2 172 174 O
indication 3 13 175 185 O
for 14 17 186 189 O
surgical 18 26 190 198 B-treatment
liver 27 32 199 204 I-treatment
resection 33 42 205 214 I-treatment

Any 0 3 215 218 O
prior 4 9 219 224 B-treatment
treatment 10 19 225 234 I-treatment
with 20 24 235 239 O
erlotinib 25 34 240 249 B-treatment
or 35 37 250 252 O
other 38 43 253 258 O
agent 44 49 259 264 O
whose 50 55 265 270 O
primary 56 63 271 278 O
mechanism 64 73 279 288 O
of 74 76 289 291 O
action 77 83 292 298 O
is 84 86 299 301 O
known 87 92 302 307 O
to 93 95 308 310 O
inhibit 96 103 311 318 O
EGFR 104 108 319 323 O

Aspartate 0 9 324 333 B-clinical_variable
aminotransferase 10 26 334 350 I-clinical_variable
( 27 28 351 352 I-clinical_variable
AST 28 31 352 355 I-clinical_variable
) 31 32 355 356 I-clinical_variable
( 33 34 357 358 B-clinical_variable
serum 34 39 358 363 I-clinical_variable
glutamic 40 48 364 372 I-clinical_variable
oxaloacetic 49 60 373 384 I-clinical_variable
transaminase 61 73 385 397 I-clinical_variable
[ 74 75 398 399 I-clinical_variable
SGOT 75 79 399 403 I-clinical_variable
] 79 80 403 404 I-clinical_variable
) 80 81 404 405 I-clinical_variable
and 82 85 406 409 O
alanine 86 93 410 417 B-clinical_variable
aminotransferase 94 110 418 434 I-clinical_variable
( 111 112 435 436 I-clinical_variable
ALT 112 115 436 439 I-clinical_variable
) 115 116 439 440 I-clinical_variable
( 117 118 441 442 B-clinical_variable
serum 118 123 442 447 I-clinical_variable
glutamate 124 133 448 457 I-clinical_variable
pyruvate 134 142 458 466 I-clinical_variable
transaminase 143 155 467 479 I-clinical_variable
[ 156 157 480 481 I-clinical_variable
SGPT 157 161 481 485 I-clinical_variable
] 161 162 485 486 I-clinical_variable
) 162 163 486 487 I-clinical_variable
= 164 165 488 489 O
< 165 166 489 490 O
5 167 168 491 492 B-upper_bound
x 169 170 493 494 I-upper_bound
institutional 171 184 495 508 I-upper_bound
ULN 185 188 509 512 I-upper_bound

Creatinine 0 10 513 523 B-clinical_variable
= 11 12 524 525 O
< 12 13 525 526 O
1.5 14 17 527 530 B-upper_bound
x 18 19 531 532 I-upper_bound
institutional 20 33 533 546 I-upper_bound
ULN 34 37 547 550 I-upper_bound

Eastern 0 7 551 558 B-clinical_variable
Cooperative 8 19 559 570 I-clinical_variable
Oncology 20 28 571 579 I-clinical_variable
Group 29 34 580 585 I-clinical_variable
( 35 36 586 587 I-clinical_variable
ECOG 36 40 587 591 I-clinical_variable
) 40 41 591 592 I-clinical_variable
performance 42 53 593 604 I-clinical_variable
status 54 60 605 611 I-clinical_variable
0 61 62 612 613 B-lower_bound
or 63 65 614 616 O
1 66 67 617 618 B-upper_bound

History 0 7 619 626 O
of 8 10 627 629 O
allergic 11 19 630 638 O
reactions 20 29 639 648 O
attributed 30 40 649 659 O
to 41 43 660 662 O
compounds 44 53 663 672 O
of 54 56 673 675 O
similar 57 64 676 683 O
chemical 65 73 684 692 O
or 74 76 693 695 O
biologic 77 85 696 704 O
composition 86 97 705 716 O
to 98 100 717 719 O
erlotinib 101 110 720 729 B-treatment
( 111 112 730 731 I-treatment
Tarceva 112 119 731 738 I-treatment
) 119 120 738 739 I-treatment

Individuals 0 11 740 751 O
with 12 16 752 756 O
a 17 18 757 758 O
clinical 19 27 759 767 O
diagnosis 28 37 768 777 O
fibrosis 38 46 778 786 B-chronic_disease
or 47 49 787 789 O
cirrhosis 50 59 790 799 B-chronic_disease
of 60 62 800 802 I-chronic_disease
the 63 66 803 806 I-chronic_disease
liver 67 72 807 812 I-chronic_disease
( 73 74 813 814 O
no 74 76 814 816 O
more 77 81 817 821 O
than 82 86 822 826 O
Child 87 92 827 832 O
- 92 93 832 833 O
Pugh 93 97 833 837 O
classification 98 112 838 852 O
A 113 114 853 854 O
; 114 115 854 855 O
Child 116 121 856 861 B-clinical_variable
- 121 122 861 862 I-clinical_variable
Pugh 122 126 862 866 I-clinical_variable
- 126 127 866 867 I-clinical_variable
Turcotte 127 135 867 875 I-clinical_variable
score 136 141 876 881 I-clinical_variable
of 142 144 882 884 O
6 145 146 885 886 B-upper_bound
or 147 149 887 889 O
less 150 154 890 894 O
) 154 155 894 895 O
who 156 159 896 899 O
have 160 164 900 904 O

International 0 13 905 918 B-clinical_variable
normalized 14 24 919 929 I-clinical_variable
ratio 25 30 930 935 I-clinical_variable
( 31 32 936 937 I-clinical_variable
INR 32 35 937 940 I-clinical_variable
) 35 36 940 941 I-clinical_variable
= 37 38 942 943 O
< 38 39 943 944 O
1.5 40 43 945 948 B-upper_bound

Non 0 3 949 952 O
- 3 4 952 953 O
surgical 4 12 953 961 O
cohort 13 19 962 968 O
only 20 24 969 973 O
: 24 25 973 974 O
pathology 26 35 975 984 O
report 36 42 985 991 O
from 43 47 992 996 O
clinical 48 56 997 1005 O
liver 57 62 1006 1011 B-treatment
biopsy 63 69 1012 1018 I-treatment
(= 70 72 1019 1021 O
< 72 73 1021 1022 O
3 74 75 1023 1024 B-upper_bound
months 76 82 1025 1031 I-upper_bound
prior 83 88 1032 1037 I-upper_bound
to 89 91 1038 1040 O
pre 92 95 1041 1044 O
- 95 96 1044 1045 O
registration 96 108 1045 1057 O
) 108 109 1057 1058 O
demonstrates 110 122 1059 1071 O
no 123 125 1072 1074 O
histologic 126 136 1075 1085 O
abnormalities 137 150 1086 1099 O
associated 151 161 1100 1110 O
with 162 166 1111 1115 O
chronic 167 174 1116 1123 B-chronic_disease
hepatitis 175 184 1124 1133 I-chronic_disease
, 184 185 1133 1134 O
steatohepatitis 186 201 1135 1150 B-chronic_disease
, 201 202 1150 1151 O
fibrosis 203 211 1152 1160 B-chronic_disease
, 211 212 1160 1161 O
or 213 215 1162 1164 O
cirrhosis 216 225 1165 1174 B-chronic_disease

Non 0 3 1175 1178 O
- 3 4 1178 1179 O
surgical 4 12 1179 1187 O
cohort 13 19 1188 1194 O
only 20 24 1195 1199 O
: 24 25 1199 1200 O
positive 26 34 1201 1209 O
phospho 35 42 1210 1217 O
- 42 43 1217 1218 O
EGFR 43 47 1218 1222 O
assessment 48 58 1223 1233 O
( 59 60 1234 1235 O
> 60 61 1235 1236 O
= 61 62 1236 1237 O
100 63 66 1238 1241 B-lower_bound
stained 67 74 1242 1249 B-clinical_variable
pixels 75 81 1250 1256 I-clinical_variable
) 81 82 1256 1257 O
from 83 87 1258 1262 O
tissue 88 94 1263 1269 O
obtained 95 103 1270 1278 O
from 104 108 1279 1283 O
previous 109 117 1284 1292 B-treatment
clinical 118 126 1293 1301 I-treatment
liver 127 132 1302 1307 I-treatment
biopsy 133 139 1308 1314 I-treatment

Not 0 3 1315 1318 B-pregnancy
pregnant 4 12 1319 1327 I-pregnancy
or 13 15 1328 1330 O
breast 16 22 1331 1337 O
feeding 23 30 1338 1345 O

Participants 0 12 1346 1358 O
who 13 16 1359 1362 O
can 17 20 1363 1366 O
not 20 23 1366 1369 O
have 24 28 1370 1374 O
their 29 34 1375 1380 O
warfarin 35 43 1381 1389 B-treatment
, 43 44 1389 1390 O
Lovenox 45 52 1391 1398 B-treatment
, 52 53 1398 1399 O
Plavix 54 60 1400 1406 B-treatment
, 60 61 1406 1407 O
or 62 64 1408 1410 O
other 65 70 1411 1416 O
comparable 71 81 1417 1427 B-treatment
medications 82 93 1428 1439 I-treatment
held 94 98 1440 1444 O
for 99 102 1445 1448 O
percutaneous 103 115 1449 1461 B-treatment
or 116 118 1462 1464 I-treatment
transjugular 119 131 1465 1477 I-treatment
liver 132 137 1478 1483 I-treatment
biopsy 138 144 1484 1490 I-treatment
and 145 148 1491 1494 O
surgery 149 156 1495 1502 B-treatment
if 157 159 1503 1505 O
so 160 162 1506 1508 O
indicated 163 172 1509 1518 O

Participants 0 12 1519 1531 O
who 13 16 1532 1535 O
regularly 17 26 1536 1545 O
( 27 28 1546 1547 O
> 28 29 1547 1548 O
= 29 30 1548 1549 O
2 31 32 1550 1551 B-lower_bound
times 33 38 1552 1557 I-lower_bound
per 39 42 1558 1561 O
week 43 47 1562 1566 O
) 47 48 1566 1567 O
use 49 52 1568 1571 O
drugs 53 58 1572 1577 O
that 59 63 1578 1582 O
alter 64 69 1583 1588 O
the 70 73 1589 1592 O
pH 74 76 1593 1595 O
of 77 79 1596 1598 O
the 80 83 1599 1602 O
gastrointestinal 84 100 1603 1619 O
( 101 102 1620 1621 O
GI 102 104 1621 1623 O
) 104 105 1623 1624 O
tract 106 111 1625 1630 O
, 111 112 1630 1631 O
such 113 117 1632 1636 O
as 118 120 1637 1639 O
proton 121 127 1640 1646 B-treatment
pump 128 132 1647 1651 I-treatment
inhibitors 133 143 1652 1662 I-treatment
( 144 145 1663 1664 I-treatment
PPI 145 148 1664 1667 I-treatment
) 148 149 1667 1668 I-treatment
and 150 153 1669 1672 O
antacids 154 162 1673 1681 B-treatment

Participants 0 12 1682 1694 O
with 13 17 1695 1699 O
a 18 19 1700 1701 O
known 20 25 1702 1707 O
diagnosis 26 35 1708 1717 O
of 36 38 1718 1720 O
human 39 44 1721 1726 B-chronic_disease
immunodeficiency 45 61 1727 1743 I-chronic_disease
virus 62 67 1744 1749 I-chronic_disease
( 68 69 1750 1751 I-chronic_disease
HIV 69 72 1751 1754 I-chronic_disease
) 72 73 1754 1755 I-chronic_disease

Percutaneous 0 12 1756 1768 B-treatment
or 13 15 1769 1771 O
transjugular 16 28 1772 1784 B-treatment
biopsy 29 35 1785 1791 I-treatment
of 36 38 1792 1794 O
cirrhotic 39 48 1795 1804 B-chronic_disease
liver 49 54 1805 1810 I-chronic_disease
at 55 57 1811 1813 O
least 58 63 1814 1819 O
7 64 65 1820 1821 B-lower_bound
days 66 70 1822 1826 I-lower_bound
prior 71 76 1827 1832 I-lower_bound
to 77 79 1833 1835 O
liver 80 85 1836 1841 B-treatment
resection 86 95 1842 1851 I-treatment
( 96 97 1852 1853 O
surgical 97 105 1853 1861 B-treatment
cohort 106 112 1862 1868 I-treatment
) 112 113 1868 1869 O

Platelets 0 9 1870 1879 B-clinical_variable
> 10 11 1880 1881 O
= 11 12 1881 1882 O
50 13 15 1883 1885 B-lower_bound
B 16 17 1886 1887 I-lower_bound
/ 17 18 1887 1888 I-lower_bound
L 18 19 1888 1889 I-lower_bound
( 20 21 1890 1891 I-lower_bound
10 21 23 1891 1893 I-lower_bound
^ 23 24 1893 1894 I-lower_bound
9 24 25 1894 1895 I-lower_bound
/ 25 26 1895 1896 I-lower_bound
L 26 27 1896 1897 I-lower_bound
) 27 28 1897 1898 I-lower_bound

Pre 0 3 1899 1902 O
- 3 4 1902 1903 O
intervention 4 16 1903 1915 O
biopsy 17 23 1916 1922 B-treatment
sample 24 30 1923 1929 O
collected 31 40 1930 1939 O

Receiving 0 9 1940 1949 O
any 10 13 1950 1953 O
other 14 19 1954 1959 O
investigational 20 35 1960 1975 B-treatment
agents 36 42 1976 1982 I-treatment
= 43 44 1983 1984 O
< 44 45 1984 1985 O
6 46 47 1986 1987 B-upper_bound
months 48 54 1988 1994 I-upper_bound
prior 55 60 1995 2000 I-upper_bound
to 61 63 2001 2003 O
registration 64 76 2004 2016 O

Surgical 0 8 2017 2025 B-treatment
cohort 9 15 2026 2032 O
( 16 17 2033 2034 O
cohort 17 23 2034 2040 O
A 24 25 2041 2042 O
only 26 30 2043 2047 O
): 30 32 2047 2049 O
percutaneous 33 45 2050 2062 B-treatment
or 46 48 2063 2065 O
transjugular 49 61 2066 2078 B-treatment
biopsy 62 68 2079 2085 I-treatment
incomplete 69 79 2086 2096 O
or 80 82 2097 2099 O
not 83 86 2100 2103 O
performed 87 96 2104 2113 O

Total 0 5 2114 2119 B-clinical_variable
bilirubin 6 15 2120 2129 I-clinical_variable
= 16 17 2130 2131 O
< 17 18 2131 2132 O
3 19 20 2133 2134 B-upper_bound
x 21 22 2135 2136 I-upper_bound
institutional 23 36 2137 2150 I-upper_bound
upper 37 42 2151 2156 I-upper_bound
limit 43 48 2157 2162 I-upper_bound
of 49 51 2163 2165 I-upper_bound
normal 52 58 2166 2172 I-upper_bound
( 59 60 2173 2174 I-upper_bound
ULN 60 63 2174 2177 I-upper_bound
) 63 64 2177 2178 I-upper_bound

Uncontrolled 0 12 2179 2191 O
intercurrent 13 25 2192 2204 B-chronic_disease
illness 26 33 2205 2212 I-chronic_disease
including 34 43 2213 2222 O
, 43 44 2222 2223 O
but 45 48 2224 2227 O
not 49 52 2228 2231 O
limited 53 60 2232 2239 O
to 61 63 2240 2242 O
, 63 64 2242 2243 O
ongoing 65 72 2244 2251 O
or 73 75 2252 2254 O
active 76 82 2255 2261 B-chronic_disease
infection 83 92 2262 2271 I-chronic_disease
, 92 93 2271 2272 O
symptomatic 94 105 2273 2284 O
congestive 106 116 2285 2295 B-chronic_disease
heart 117 122 2296 2301 I-chronic_disease
failure 123 130 2302 2309 I-chronic_disease
, 130 131 2309 2310 O
unstable 132 140 2311 2319 B-chronic_disease
angina 141 147 2320 2326 I-chronic_disease
pectoris 148 156 2327 2335 I-chronic_disease
, 156 157 2335 2336 O
or 158 160 2337 2339 O
psychiatric 161 172 2340 2351 B-chronic_disease
illness 173 180 2352 2359 I-chronic_disease
/ 180 181 2359 2360 O
social 181 187 2360 2366 B-chronic_disease
situations 188 198 2367 2377 I-chronic_disease
that 199 203 2378 2382 O
would 204 209 2383 2388 O
limit 210 215 2389 2394 O
compliance 216 226 2395 2405 O
with 227 231 2406 2410 O
study 232 237 2411 2416 O
requirements 238 250 2417 2429 O

Use 0 3 2430 2433 O
of 4 6 2434 2436 O
potent 7 13 2437 2443 O
CYP3A4 14 20 2444 2450 O
inhibitors 21 31 2451 2461 O
, 31 32 2461 2462 O
such 33 37 2463 2467 O
as 38 40 2468 2470 O
ketoconazole 41 53 2471 2483 B-treatment
, 53 54 2483 2484 O
atazanavir 55 65 2485 2495 B-treatment
, 65 66 2495 2496 O
clarithromycin 67 81 2497 2511 B-treatment
, 81 82 2511 2512 O
indinavir 83 92 2513 2522 B-treatment
, 92 93 2522 2523 O
itraconazole 94 106 2524 2536 B-treatment
, 106 107 2536 2537 O
nefazodone 108 118 2538 2548 B-treatment
, 118 119 2548 2549 O
nelfinavir 120 130 2550 2560 B-treatment
, 130 131 2560 2561 O
ritonavir 132 141 2562 2571 B-treatment
, 141 142 2571 2572 O
saquinavir 143 153 2573 2583 B-treatment
, 153 154 2583 2584 O
telithromycin 155 168 2585 2598 B-treatment
, 168 169 2598 2599 O
troleandomycin 170 184 2600 2614 B-treatment
, 184 185 2614 2615 O
voriconazole 186 198 2616 2628 B-treatment
, 198 199 2628 2629 O
and 200 203 2630 2633 O
grapefruit 204 214 2634 2644 B-treatment
or 215 217 2645 2647 O
grapefruit 218 228 2648 2658 B-treatment
juice 229 234 2659 2664 I-treatment

Willingness 0 11 2665 2676 O
to 12 14 2677 2679 O
authorize 15 24 2680 2689 O
collection 25 35 2690 2700 O
of 36 38 2701 2703 O
tissue 39 45 2704 2710 O
from 46 50 2711 2715 O
surgically 51 61 2716 2726 B-treatment
- 61 62 2726 2727 I-treatment
resected 62 70 2727 2735 I-treatment
liver 71 76 2736 2741 I-treatment
or 77 79 2742 2744 O
clinical 80 88 2745 2753 O
liver 89 94 2754 2759 B-treatment
biopsy 95 101 2760 2766 I-treatment
for 102 105 2767 2770 O
analyses 106 114 2771 2779 O

Willingness 0 11 2780 2791 O
to 12 14 2792 2794 O
discontinue 15 26 2795 2806 O
smoking 27 34 2807 2814 O
during 35 41 2815 2821 O
the 42 45 2822 2825 O
study 46 51 2826 2831 O
two 52 55 2832 2835 B-upper_bound
weeks 56 61 2836 2841 I-upper_bound
prior 62 67 2842 2847 I-upper_bound
to 68 70 2848 2850 O
beginning 71 80 2851 2860 O
the 81 84 2861 2864 O
study 85 90 2865 2870 O
and 91 94 2871 2874 O
willingness 95 106 2875 2886 O
to 107 109 2887 2889 O
not 110 113 2890 2893 O
smoke 114 119 2894 2899 O
while 120 125 2900 2905 O
taking 126 132 2906 2912 O
study 133 138 2913 2918 B-treatment
medication 139 149 2919 2929 I-treatment

Willingness 0 11 2930 2941 B-contraception_consent
to 12 14 2942 2944 I-contraception_consent
use 15 18 2945 2948 I-contraception_consent
adequate 19 27 2949 2957 I-contraception_consent
contraception 28 41 2958 2971 I-contraception_consent
to 42 44 2972 2974 O
avoid 45 50 2975 2980 O
pregnancy 51 60 2981 2990 B-pregnancy
or 61 63 2991 2993 O
impregnation 64 76 2994 3006 B-pregnancy
until 77 82 3007 3012 O
2 83 84 3013 3014 B-upper_bound
weeks 85 90 3015 3020 I-upper_bound
after 91 96 3021 3026 I-upper_bound
discontinuing 97 110 3027 3040 O
study 111 116 3041 3046 B-treatment
agent 117 122 3047 3052 I-treatment

individuals 0 11 3053 3064 O
who 12 15 3065 3068 O
use 16 19 3069 3072 O
prescription 20 32 3073 3085 O
PPIs 33 37 3086 3090 B-treatment
and 38 41 3091 3094 O
have 42 46 3095 3099 O
approval 47 55 3100 3108 O
from 56 60 3109 3113 O
their 61 66 3114 3119 O
primary 67 74 3120 3127 O
health 75 81 3128 3134 O
care 82 86 3135 3139 O
provider 87 95 3140 3148 O
to 96 98 3149 3151 O
discontinue 99 110 3152 3163 O
for 111 114 3164 3167 O
the 115 118 3168 3171 O
duration 119 127 3172 3180 O
of 128 130 3181 3183 O
clinical 131 139 3184 3192 O
trial 140 145 3193 3198 O
participation 146 159 3199 3212 O
may 160 163 3213 3216 O
be 164 166 3217 3219 O
enrolled 167 175 3220 3228 O
; 175 176 3228 3229 O
an 177 179 3230 3232 O
alternate 180 189 3233 3242 B-treatment
drug 190 194 3243 3247 I-treatment
to 195 197 3248 3250 O
control 198 205 3251 3258 O
gastroesophageal 206 222 3259 3275 B-chronic_disease
reflux 223 229 3276 3282 I-chronic_disease
disease 230 237 3283 3290 I-chronic_disease
( 238 239 3291 3292 I-chronic_disease
GERD)/peptic 239 251 3292 3304 I-chronic_disease
ulcer 252 257 3305 3310 I-chronic_disease
disease 258 265 3311 3318 I-chronic_disease
( 266 267 3319 3320 I-chronic_disease
PUD 267 270 3320 3323 I-chronic_disease
) 270 271 3323 3324 I-chronic_disease
symptoms 272 280 3325 3333 O
will 281 285 3334 3338 O
be 286 288 3339 3341 O
suggested 289 298 3342 3351 O

se 0 2 3352 3354 O
of 3 5 3355 3357 O
CYP3A4 6 12 3358 3364 B-treatment
inducers 13 21 3365 3373 I-treatment
such 22 26 3374 3378 O
as 27 29 3379 3381 O
rifampicin 30 40 3382 3392 B-treatment
, 40 41 3392 3393 O
rifabutin 42 51 3394 3403 B-treatment
, 51 52 3403 3404 O
rifapentine 53 64 3405 3416 B-treatment
, 64 65 3416 3417 O
phenytoin 66 75 3418 3427 B-treatment
, 75 76 3427 3428 O
carbamazepine 77 90 3429 3442 B-treatment
, 90 91 3442 3443 O
phenobarbital 92 105 3444 3457 B-treatment
, 105 106 3457 3458 O
and 107 110 3459 3462 O
St. 111 114 3463 3466 B-treatment
John 115 119 3467 3471 I-treatment
's 119 121 3471 3473 I-treatment
wort 122 126 3474 3478 I-treatment

women 0 5 3479 3484 B-gender
of 6 8 3485 3487 O
child 9 14 3488 3493 O
- 14 15 3493 3494 O
bearing 15 22 3494 3501 O
potential 23 32 3502 3511 O
and 33 36 3512 3515 O
men 37 40 3516 3519 O
must 41 45 3520 3524 O
agree 46 51 3525 3530 B-contraception_consent
to 52 54 3531 3533 I-contraception_consent
use 55 58 3534 3537 I-contraception_consent
adequate 59 67 3538 3546 I-contraception_consent
contraception 68 81 3547 3560 I-contraception_consent
( 82 83 3561 3562 I-contraception_consent
hormonal 83 91 3562 3570 I-contraception_consent
or 92 94 3571 3573 I-contraception_consent
barrier 95 102 3574 3581 I-contraception_consent
method 103 109 3582 3588 I-contraception_consent
of 110 112 3589 3591 I-contraception_consent
birth 113 118 3592 3597 I-contraception_consent
control 119 126 3598 3605 I-contraception_consent
; 126 127 3605 3606 I-contraception_consent
abstinence 128 138 3607 3617 I-contraception_consent
) 138 139 3617 3618 I-contraception_consent
prior 140 145 3619 3624 O
to 146 148 3625 3627 O
study 149 154 3628 3633 O
entry 155 160 3634 3639 O
and 161 164 3640 3643 O
for 165 168 3644 3647 O
the 169 172 3648 3651 O
duration 173 181 3652 3660 O
of 182 184 3661 3663 O
study 185 190 3664 3669 O
participation 191 204 3670 3683 O

